Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gore

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Genetic Testing|September 4, 2004
High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive studyNina Hallowell, James Mackay, Martin Richards, et al.
Melanoma Research|December 6, 2012
Ipilimumab activity in advanced uveal melanomaMuhammad Adnan Khattak, Rosalie Fisher, Peta Hughes, et al.
Cancer Treatment Reviews|August 21, 2003
Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trialsKeith Wheatley, Natalie Ives, Barry Hancock, et al.
Frontiers in Oncology|June 2, 2015
Pazopanib-induced alopecia, an underestimated toxicity?Andrea Biondo, Helen Alexander, Komel Khabra, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2016
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case seriesLavinia Spain, Gerard Walls, Christina Messiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenibRishika Sinha, Kim Edmonds, Julia Newton-Bishop, et al.
Pigment Cell & Melanoma Research|January 15, 2013
Human endogenous retrovirus K (HERV-K) rec mRNA is expressed in primary melanoma but not in benign naevi or normal skinSarita Singh, Steve Kaye, Nick Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinibJames Larkin, Rosalie Fisher, Lisa Pickering, et al.
Pigment Cell & Melanoma Research|September 29, 2015
Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastasesHeike Seifert, Eishu Hirata, Martin Gore, et al.
Melanoma Research|April 11, 2015
The cost of ipilimumab toxicity: a single-centre analysisNadia Yousaf, Michael Davidson, Emily Goode, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Genetic Testing|September 4, 2004
High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive studyNina Hallowell, James Mackay, Martin Richards, et al.
Melanoma Research|December 6, 2012
Ipilimumab activity in advanced uveal melanomaMuhammad Adnan Khattak, Rosalie Fisher, Peta Hughes, et al.
Cancer Treatment Reviews|August 21, 2003
Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trialsKeith Wheatley, Natalie Ives, Barry Hancock, et al.
Frontiers in Oncology|June 2, 2015
Pazopanib-induced alopecia, an underestimated toxicity?Andrea Biondo, Helen Alexander, Komel Khabra, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 2016
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case seriesLavinia Spain, Gerard Walls, Christina Messiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2013
Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenibRishika Sinha, Kim Edmonds, Julia Newton-Bishop, et al.
Pigment Cell & Melanoma Research|January 15, 2013
Human endogenous retrovirus K (HERV-K) rec mRNA is expressed in primary melanoma but not in benign naevi or normal skinSarita Singh, Steve Kaye, Nick Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to sunitinibJames Larkin, Rosalie Fisher, Lisa Pickering, et al.
Pigment Cell & Melanoma Research|September 29, 2015
Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastasesHeike Seifert, Eishu Hirata, Martin Gore, et al.
Melanoma Research|April 11, 2015
The cost of ipilimumab toxicity: a single-centre analysisNadia Yousaf, Michael Davidson, Emily Goode, et al.
Pageof 14